Correction to: Primary Tumor Resection for Stage IV Non-small-cell Lung Cancer Without Progression After First-Line Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment: A Retrospective Case-Control Study
Ann Surg Oncol. 2022 Aug;29(8):4922.
doi: 10.1245/s10434-022-11714-x.
1 Division of Thoracic Surgery, Department of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei City, 100, Taiwan.
2 Division of Thoracic Surgery, Department of Surgery, National Taiwan University Hospital Yun-Lin Branch, Douliu City, Taiwan.
3 Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei City, 100, Taiwan.
4 Department of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei City, 100, Taiwan.
5 Department of Traumatology, National Taiwan University Hospital, Taipei City, 100, Taiwan.
6 Department of Surgery, Taipei City Hospital, Taipei City, 115, Taiwan.
7 Department of Surgical Oncology, National Taiwan University Cancer Center, National Taiwan University College of Medicine, Taipei City, 106, Taiwan.
8 Division of Thoracic Surgery, Department of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei City, 100, Taiwan. [email protected].
9 Department of Surgical Oncology, National Taiwan University Cancer Center, National Taiwan University College of Medicine, Taipei City, 106, Taiwan. [email protected].